Knockdown of FBN1 in vivo
Male C57/BL6 mice weighing 21–24 g were divided into three groups (n=6 in each group): (i) sham-operated mice, (ii) UIRI mice injected with control shRNA, and (iii) UIRI mice injected with FBN1-shRNA. Four days after IRI, mice were injected with either pLVX-shFBN1 or control (pLVX-control) plasmids via tail vein injection using hydrodynamics-based gene transfer approach. Plasmids were diluted with sterile PBS. The amount of plasmid for mice was 1 mg per kg body weight. The fluid volume via tail-vein injection of each mouse is about 10% of the body weight, and FBN1 or control shRNA should be rapidly administered (within 10 seconds) into mice via tail-vein injection. Mice were euthanized at 11 days after IRI, and serum and kidney tissues were analyzed.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this
article to respond.